Anika Therapeutics enters Fifth Amendment to credit agreement, $50M revolver due 2031

Anika Therapeutics, Inc.

$50M senior revolving credit facility with Bank of America, maturity July 10, 2031.
Option to increase commitments by up to $50M (total $100M) subject to lender approval.
Interest rate: SOFR plus 0.25%-1.25% based on leverage ratio; commitment fee 0.20%-0.30% on unused portion.
Financial covenants include max leverage and interest coverage ratios; first-priority lien on substantially all assets.
Amendment reduces revolving facility from prior amount to $50M; certain lenders exit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.